help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on November 1, 2007, doi:10.1164/rccm.200608-1190PP

Am. J. Respir. Crit. Care Med., Volume 177, Number 4, February 2008, 369-375

A more recent version of this article appeared on February 15, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200608-1190PPv1
177/4/369    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gozal, D.
Right arrow Articles by Kheirandish-Gozal, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gozal, D.
Right arrow Articles by Kheirandish-Gozal, L.

Submitted on August 21, 2006
Accepted on November 1, 2007

Cardiovascular Morbidity in Obstructive Sleep Apnea: Oxidative Stress, Inflammation, and Much More

David Gozal1* and Leila Kheirandish-Gozal1

1 Division of Pediatric Sleep Medicine, Department of Pediatrics, Kosair Children's Hospital Research Institute, University of Louisville, Louisville, KY, USA

* To whom correspondence should be addressed. E-mail: david.gozal{at}louisville.edu.

Sleep-disordered breathing and obstructive sleep apnea (OSA) are highly prevalent disorders throughout the lifespan, which may affect up to 2-10% of the population, and have now been firmly associated with an increased risk for cardiovascular and neurobehavioral complications. Nevertheless, the overall pathophysiological mechanisms mediating end-organ injury in OSA remain undefined, particularly due to the very frequent co-existence of other disease states such as obesity, that clearly complicate the potential cause-effect relationships. Two major and to some extent overlapping mechanisms have been proposed to explain the morbid consequences of OSA, namely increased generation and propagation of reactive oxygen species and initiation and amplification of inflammatory processes. The evidence supporting the validity of these concepts as well as that detracting from such mechanisms will be critically reviewed in the context of clinical and laboratory-based approaches. In addition, some of the contradictory issues raised by such evaluation of the literature will be interpreted in the context of putative modifications of the individual responses to OSA, as determined by genetic variants among susceptibility-related genes, and also by potential environmental modulators of the phenotypic expression of any particular end-organ morbidity associated with OSA.


Key words: inflammation; oxidative stress; reactive oxygen species; intermittent hypoxia; sleep fragmentation




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
T. D. Bradley
Respiratory Sleep Medicine: A Coming of Age
Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 363 - 364.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society